Description

Trade name:

Vastaflam

Compound:

Each film-coated tablet contains:

Diclofenac sodium 50 mg.

Excipients: anhydrous dibasic calcium phosphate, microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, sodium starch glycolate, sucrose, gum, corn starch, talc, red iron oxide, titanium dioxide.

Properties:

Diclofenac sodium is a non-steroidal drug with pronounced antirheumatic, analgesic, anti-inflammatory and antipyretic properties.

Properties:

Osteoarthritis, low back pain, acute musculoskeletal disorders and injuries, bursitis, sprains, strains and dislocations, relief of fracture pain, ankylosing spondylitis, acute gout, rheumatoid arthritis, migraine attacks. Control of pain and inflammation in orthopedic, dental and other minor surgeries. Children aged 9 years and above: short-term treatment of fever associated with ear, nose and throat (ENT) infections, such as pharyngotonsillitis, otitis media.

Directions for use and dosage:

For oral administration, the tablets should be swallowed whole with liquid, with or after food. The lowest effective dose to control symptoms is used: the recommended daily dose is 100-150 mg in 2 or 3 divided doses. In milder cases, 75-100 mg per day in 2 or 3 divided doses is sufficient. For migraine, the initial dose is 50 mg – at the first sign of an attack. If relief does not occur within 2 hours after the first dose, an additional dose of 50 mg may be taken. If necessary, additional doses of 50 mg can be taken at intervals of 4-6 hours, not exceeding a total dose of 200 mg per day.

Children 12 years and older: The recommended daily dose is 75-100 mg in 2 or 3 divided doses. Children 9 years (minimum 35 kg body weight) or older and adolescents should be given up to 2 mg/kg body weight per day in 3 divided doses, depending on the severity of the disorder.

Contraindications:

Children under 12 years of age; hypersensitivity to any component of the drug, aspirin; severe cardiac, hepatic, renal failure; bradycardia, severe arterial hypotension; gastric bleeding; pregnancy, lactation.

Precautions:

In case of liver diseases, the drug should be discontinued. Patients with heart and vascular diseases should be under the supervision of a physician during therapy. Weak and elderly patients, patients with low body weight should use minimal therapeutically effective doses. Before prescribing the drug, it is necessary to undergo a clinical examination of patients with peptic ulcers; with a history of intestinal bleeding; with liver and kidney damage, including in the history; with high blood pressure. In case of bronchial asthma, hay fever, acute and chronic respiratory pathologies, in patients with nasal polyps, taking the drug can cause asthma attacks. Treatment of these conditions is symptomatic.

Side effects:

Headaches, dizziness; vertigo; tachycardia/bradycardia, arterial hypertension, arrhythmia, heart failure; abdominal pain, vomiting, cramps, flatulence, nausea, diarrhea, dyspepsia; fluid retention, edema; rash, angioedema.